Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	Wiley 2018-07-01
Cyfres:	Reproductive Medicine and Biology
Pynciau:	assisted reproductive technology atypical endometrial hyperplasia conservative treatment endometrial carcinoma medroxyprogesterone acetate
Mynediad Ar-lein:	https://doi.org/10.1002/rmb2.12209

Eitemau Tebyg

Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
gan: Vakkas Korkmaz, et al.
Cyhoeddwyd: (2013-08-01)

Results of surgical treatment of atypical endometrial hyperplasia
gan: O. A. Gornykh, et al.
Cyhoeddwyd: (2014-07-01)

Modern approaches to the diagnosis of endometrial hyperplasia
gan: M. M. Damirov, et al.
Cyhoeddwyd: (2025-02-01)

Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
gan: А. E. Protasova, et al.
Cyhoeddwyd: (2024-07-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
gan: An-Ju Chou, et al.
Cyhoeddwyd: (2024-11-01)

Endometrial hyperplasia and progesterone resistance: a complex relationship
gan: Mekan R. Orazov, et al.
Cyhoeddwyd: (2023-03-01)

The reproductive function of patients with prior atypical endometrial hyperplasia and endometrial cancer treatment: cohort study
gan: Lana G. Dzhanashvili, et al.
Cyhoeddwyd: (2022-09-01)

Trans-vaginal sono-elastography in the differentiation of endometrial hyperplasia and endometrial carcinoma
gan: Mahmoud Abdel Latif, et al.
Cyhoeddwyd: (2016-09-01)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
gan: Fariba Behnamfar, et al.
Cyhoeddwyd: (2014-01-01)

Reproductive advance of fertility preservation in patients with early endometrial carcinoma or endometrial atypical hyperplasia
gan: Jiao Yu, et al.
Cyhoeddwyd: (2022-12-01)

Laparoscopic surgery for atypical endometrial hyperplasia with awareness regarding the possibility of endometrial cancer
gan: Misato Kamii, et al.
Cyhoeddwyd: (2023-01-01)

Features of the course of pregnancy and childbirth after conservative treatment of initial atypical hyperplasia and endometrial cancer
gan: A. V. Charkhifalakyan, et al.
Cyhoeddwyd: (2025-01-01)

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women
gan: Stefano Uccella, et al.
Cyhoeddwyd: (2022-09-01)

The retrospective analysis results of the endometrial tissue pathological conditions development
gan: V. V. Artyomenko, et al.
Cyhoeddwyd: (2020-11-01)

Recurrent endometrial atypical hyperplasia diagnosed by pathological examination of the placenta from a live birth: a case report
gan: Weilu Wu, et al.
Cyhoeddwyd: (2023-09-01)

Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia
gan: Pinar Kadirogullari, et al.
Cyhoeddwyd: (2015-10-01)

Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes
gan: Xu S, et al.
Cyhoeddwyd: (2025-02-01)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
gan: Junyu Chen, et al.
Cyhoeddwyd: (2021-09-01)

Liquid-based endometrial cytology associated with curettage in the investigation of endometrial carcinoma in postmenopausal women
gan: Ke Ma, et al.
Cyhoeddwyd: (2016-12-01)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
gan: Jun Guan, et al.
Cyhoeddwyd: (2022-10-01)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
gan: Junyu Chen, et al.
Cyhoeddwyd: (2022-02-01)

Clinical features and outcome of 15 patients with recurrent endometrial cancer or atypical endometrial hyperplasia received primary fertility-sparing therapy followed by hysterectomy
gan: Yuanting Li, et al.
Cyhoeddwyd: (2021-03-01)

The proliferation markers in patients with different forms of hyperplastic endometrial processes
gan: Yuri Krut, et al.
Cyhoeddwyd: (2022-05-01)

Risk of endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia treated with total laparoscopic hysterectomy
gan: Katsutoshi Oda, et al.
Cyhoeddwyd: (2016-05-01)

Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
gan: Xinxin Zhu, et al.
Cyhoeddwyd: (2023-12-01)

Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia
gan: Yu-Li Chen, et al.
Cyhoeddwyd: (2009-06-01)

Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia
gan: Pengfei Wu, et al.
Cyhoeddwyd: (2024-01-01)

ENDOMETRIAL PRECANCER: DEFINITION OF CONCEPTS, TACTICS
gan: Iu. Iu. Tabakman, et al.
Cyhoeddwyd: (2016-09-01)

Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors
gan: Luca Giannella, et al.
Cyhoeddwyd: (2020-07-01)

Evaluation of Diagnostic Efficacy of Pipelle Endometrial Sampling in Abnormal Uterine Bleeding
gan: ABILASH SASIDHARANNAIR CHANDRAKUMARI, et al.
Cyhoeddwyd: (2018-05-01)

Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases
gan: Junyu Chen, et al.
Cyhoeddwyd: (2024-06-01)

Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment
gan: Yaxing Guo, et al.
Cyhoeddwyd: (2022-06-01)

Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery <sup>†</sup>
gan: Yaochen Lou, et al.
Cyhoeddwyd: (2021-12-01)

Clinical, Sonographic, and Hysteroscopic Features of Endometrial Carcinoma Diagnosed after Hysterectomy in Patients with a Preoperative Diagnosis of Atypical Hyperplasia: A Single-Center Retrospective Study
gan: Luca Pace, et al.
Cyhoeddwyd: (2022-12-01)

New classification system of endometrial hyperplasia WHO 2014 and its clinical implications
gan: Katarzyna Sobczuk, et al.
Cyhoeddwyd: (2017-10-01)

Concurrent endometrial intraepithelial carcinoma (EIC) and endometrial hyperplasia
gan: Steven Wang, MD, et al.
Cyhoeddwyd: (2015-03-01)

Age-related relationship between the development of hyperplastic processes and VEGF expression in endometrial cells
gan: Z. V. Chumak, et al.
Cyhoeddwyd: (2020-04-01)

The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study
gan: Jin-Sung Yuk
Cyhoeddwyd: (2016-08-01)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
gan: Lee Shi Hui, et al.
Cyhoeddwyd: (2021-05-01)

Effects of isoflavone supplementation on endometrial thickness, endometrial hyperplasia, and cancer in ovariectomized cats
gan: Mona Negadmonfared, et al.
Cyhoeddwyd: (2022-01-01)